These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27729735)

  • 21. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular insights into cancer drug resistance from a proteomics perspective.
    An Y; Zhou L; Huang Z; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2019 May; 16(5):413-429. PubMed ID: 30925852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineating protein biomarkers for gastric cancers: A catalogue of mass spectrometry-based markers and assessment of their suitability for targeted proteomics applications.
    Ramesh P; Nisar M; Neha ; Ammankallu S; Babu S; Nandakumar R; Abhinand CS; Prasad TSK; Codi JAK; Raju R
    J Proteomics; 2024 Aug; 306():105262. PubMed ID: 39047941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry.
    Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT
    Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometry and protein analysis.
    Domon B; Aebersold R
    Science; 2006 Apr; 312(5771):212-7. PubMed ID: 16614208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
    Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
    J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based identification of a group of apoptosis-related proteins and biomarkers in gastric cancer.
    Bai Z; Ye Y; Liang B; Xu F; Zhang H; Zhang Y; Peng J; Shen D; Cui Z; Zhang Z; Wang S
    Int J Oncol; 2011 Feb; 38(2):375-83. PubMed ID: 21165559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectrometry based proteomics for absolute quantification of proteins from tumor cells.
    Wang H; Hanash S
    Methods; 2015 Jun; 81():34-40. PubMed ID: 25794949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of tumor markers for gastric cancer by proteomics.
    Wu JY; Cheng CC; Wang JY; Wu DC; Hsieh JS; Lee SC; Wang WM
    PLoS One; 2014; 9(1):e84158. PubMed ID: 24404153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Identification of biomarkers in the serum of the patients with poorly differentiated gastric cancer].
    Li W; Liu BY; Li JF; Chen XH; Hao JH; Cai Q; Gu QL; Zhu ZG; Lin YZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):253-6. PubMed ID: 16721691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of mass spectrometry-based proteomics and metabolomics in basic and translational research.
    Kelleher NL
    Biochemistry; 2013 Jun; 52(22):3794-6. PubMed ID: 23614658
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantify this! Report on a round table discussion on quantitative mass spectrometry in proteomics.
    Quadroni M; Ducret A; Stöcklin R
    Proteomics; 2004 Aug; 4(8):2211-5. PubMed ID: 15274113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study.
    Abramowicz A; Wojakowska A; Gdowicz-Klosok A; Polanska J; Rodziewicz P; Polanowski P; Namysl-Kaletka A; Pietrowska M; Wydmanski J; Widlak P
    J Transl Med; 2015 Sep; 13():304. PubMed ID: 26376850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
    Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
    Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative proteomics of apoptosis initiation induced by 5-fluorouracil in human gastric cancer.
    Chen CY; Jia JH; Zhang MX; Zhou YB; Zhang RM; Yu XP
    Chin J Physiol; 2006 Feb; 49(1):31-8. PubMed ID: 16900703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proteomic identification and comparison of differentiation-related proteins in gastric carcinoma cell lines].
    Li Y; Tan BB; Fan LQ; Zhao Q; Song ZC; Wang D
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):179-84. PubMed ID: 20450584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of a current role of mass spectrometry for proteome research.
    Chen CH
    Anal Chim Acta; 2008 Aug; 624(1):16-36. PubMed ID: 18706308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.